ArticleFrontiers in oncology2025

Persistent bothersome urinary frequency following stereotactic body radiation therapy for clinically localized prostate cancer: rationale for prophylactic β3-agonist in men with elevated baseline international prostate symptom scores.

Jennifer Zack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.